Cargando…

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines

Detalles Bibliográficos
Autores principales:	Wu, Chia-Chao, Lu, Kuo-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426214/ https://www.ncbi.nlm.nih.gov/pubmed/34521583 http://dx.doi.org/10.1016/j.ejim.2021.09.005

Ejemplares similares

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
por: Inserra, Felipe, et al.
Publicado: (2021)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Poor Response to Inactivated SARS-CoV-2 Vaccine in Patients With Chronic Liver Disease
por: Cao, Huanhuan, et al.
Publicado: (2022)

Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination
por: Aydın, Mehmet Fethullah, et al.
Publicado: (2021)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Relapse of minimal change disease and inactivated SARS-CoV-2 vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients
por: Zhang, Yue-Miao, et al.
Publicado: (2022)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

T(FH)2 cells associate with enhanced humoral immunity to SARS‐CoV‐2 inactivated vaccine in patients with allergic rhinitis
por: Yao, Yin, et al.
Publicado: (2022)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Acceptance, safety and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in adults with tuberculosis
por: Zhan, Haoting, et al.
Publicado: (2023)

Instantaneous “catch‐and‐kill” inactivation of SARS‐CoV‐2 by nitride ceramics
por: Pezzotti, Giuseppe, et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibody, glomerulonephritis and inactivated SARS‐CoV‐2 vaccine: comment on the article by Garcia et al
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces
por: Gerlach, M., et al.
Publicado: (2020)

Rapid inactivation of SARS-CoV-2 after exposure to vapour hydrogen peroxide
por: Pottage, T., et al.
Publicado: (2021)

Relapse of minimal change disease after inactivated SARS-CoV-2 vaccination: case report
por: Özkan, Gülsüm, et al.
Publicado: (2021)

Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
por: Xie, Xiaochun, et al.
Publicado: (2021)

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
por: Li, Xue, et al.
Publicado: (2023)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Long-term antibody response to inactivated SARS-CoV-2 vaccination in patients with chronic liver disease: A multicenter study
por: Yang, Yinuo, et al.
Publicado: (2023)

Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia
por: Carrabba, Maria, et al.
Publicado: (2022)

Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients: an initial report
por: Boongird, Sarinya, et al.
Publicado: (2021)

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine
por: Zhou, Xingdong, et al.
Publicado: (2021)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

SARS-CoV-2 main protease Nsp5 cleaves and inactivates human tRNA methyltransferase TRMT1
por: Lu, Jia-Li, et al.
Publicado: (2023)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rmevqtm3e8pgjkf6im4tvcd2s5